Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 39
Filtrar
1.
Am J Perinatol ; 29(4): 245-50, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21809262

RESUMEN

Assisted reproductive technology using donor-egg in vitro fertilization (D-IVF) has enabled women 50 years and above to successfully achieve pregnancy. We examine the safety profile of these pregnancies through a large, single-center case series and retrospective cohort analysis in which all participants were carefully screened medically prior to conception. Consecutive women aged ≥ 50 years (n = 101) who achieved a viable pregnancy via D-IVF were identified and their perinatal outcomes were recorded. These data were compared with control data from younger (≤ 42 years) recipients of D-IVF (n = 41) who also achieved a viable pregnancy at our center during the same period. Compared with the younger women, older recipients had statistically similar rates of hypertensive disorders of pregnancy (23% versus 14%, odds ratio [OR] 1.9 [0.65 to 5.4]), gestational diabetes (4.0% versus 3.0%, OR 1.4 [0.15 to 113.0]), preterm premature rupture of membranes/preterm labor (8.9% versus 14%, OR 0.59 [0.18 to 1.9]), and abnormal placentation (2.1% versus 0%). Cesarean delivery was high in women ≥ 50 (81% of singletons, 100% of multiples). There was one maternal death, which occurred before delivery in a 49-year-old woman who would have been 50 at term had she survived, presumably secondary to myocardial infarction. Primary neonatal outcomes of gestational age and birth weight were excellent and similar between groups. Women ≥ 50 years who achieve pregnancy via D-IVF are at high risk for maternal complications, particularly hypertensive disorders and cesarean section, but at rates similar to those seen in younger recipients.


Asunto(s)
Peso al Nacer , Fertilización In Vitro , Edad Gestacional , Edad Materna , Donación de Oocito , Complicaciones del Embarazo/epidemiología , Adulto , Estudios de Casos y Controles , Cesárea/estadística & datos numéricos , Estudios de Cohortes , Femenino , Humanos , Hipertensión Inducida en el Embarazo/epidemiología , Recién Nacido , Persona de Mediana Edad , Trabajo de Parto Prematuro/epidemiología , Embarazo , Estudios Retrospectivos
2.
Obstet Gynecol ; 116(1): 58-62, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20567168

RESUMEN

OBJECTIVE: To further evaluate the relationship between thyroid antibodies and preterm births. METHODS: This is a prospective study of pregnancy outcome and demographic data combined with retrospective measurement of thyroperoxidase and thyroglobulin antibodies. Sera were obtained at 11-13 and 15-18 weeks of gestation from 10,062 women with singleton viable pregnancies (a subset from the First- and Second-Trimester Risk of Aneuploidy [FaSTER] trial). RESULTS: Women with elevated levels of thyroperoxidase, thyroglobulin antibodies, or both in the first trimester have a higher rate of preterm delivery before 37 weeks of gestation than antibody-negative women (7.5% compared with 6.4%, odds ratio [OR] 1.18; 95% confidence interval [CI] 0.95-1.46). This is also the case for very preterm delivery before 32 weeks of gestation (1.2% compared with 0.7%, OR 1.70; 95% CI 0.98-2.94). Preterm premature rupture of membranes is also increased (2.0% compared with 1.2%, OR 1.67; 95% CI 1.05-2.44). These associations are less strong for second-trimester antibody measurements. CONCLUSION: The present data do not confirm strong associations between thyroid antibody elevations and preterm birth found in three of five previously published reports. Preterm premature rupture of membranes appears to contribute to the thyroid antibody-associated early deliveries, possibly as a result of inflammation. LEVEL OF EVIDENCE: II.


Asunto(s)
Autoanticuerpos/sangre , Yoduro Peroxidasa/inmunología , Nacimiento Prematuro/etiología , Adulto , Femenino , Rotura Prematura de Membranas Fetales/inmunología , Humanos , Embarazo , Primer Trimestre del Embarazo , Estudios Prospectivos , Estudios Retrospectivos
3.
Am J Perinatol ; 26(5): 351-5, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19067281

RESUMEN

We evaluated outcomes following tocolysis discontinuation in singleton pregnancies between 33.0 and 36.9 weeks' gestation. We performed a retrospective analysis of singleton pregnancies prescribed continuous subcutaneous terbutaline tocolysis. Patients without indicated preterm delivery discontinuing treatment between 33.0 and 36.9 weeks were evaluated ( N = 4253). Data were grouped by week at treatment discontinuation. Outcomes were compared for each week. Approximately 55% (2316/4253) delivered preterm (< 37 weeks). After treatment discontinuation, 58.1% (2472/4253) of patients delivered within 7 days and 41.2% (1752/4253) within 3 days. Median number of days from discontinuation to delivery was 5 (range, 0 to 65). Incidence of low birth weight (< or = 2500 g), neonatal intensive care unit admissions, days in nursery, and estimated charges decreased with each additional week of tocolysis (all P < 0.05, adjusted for multiple comparisons). Tocolysis discontinuation prior to term is associated with late-preterm birth, adverse neonatal outcomes, and increased estimated health care costs.


Asunto(s)
Nacimiento Prematuro/tratamiento farmacológico , Nacimiento Prematuro/epidemiología , Tocólisis/estadística & datos numéricos , Adolescente , Adulto , Comorbilidad , Femenino , Georgia/epidemiología , Edad Gestacional , Humanos , Recién Nacido , Estado Civil , Edad Materna , Persona de Mediana Edad , Embarazo , Resultado del Embarazo , Tercer Trimestre del Embarazo , Grupos Raciales/estadística & datos numéricos , Recurrencia , Estudios Retrospectivos , Fumar/epidemiología , Terbutalina/uso terapéutico , Tocolíticos/uso terapéutico , Adulto Joven
4.
Int Rev Neurobiol ; 83: 273-82, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18929088

RESUMEN

Women with epilepsy who take antiseizure medicines have successful and unremarkable pregnancies the majority of the time. Achieving seizure freedom is important for successful pregnancies, and it is also highly predictive of seizure freedom during pregnancy. From data derived from the general population, vitamin supplementation is important to prevent birth defects, and women with epilepsy of child-bearing potential should be encouraged to take folic acid supplements daily. Pregnant women with epilepsy should have their pregnancies screened for neural tube defects with a maternal serum alpha-feto-protein level at 15-16 weeks of gestational age and an anatomical survey by ultrasound at 18-22 weeks of gestation. Pregnant women with epilepsy do face a higher risk of both non-proteinuric hypertension and induction of labor than do then general population, as well as an approximately twofold risk of cesarean section. However, the indication for cesarean section is unclear and appears not to be related to fetal distress and may in part be influenced by caution at the time of delivery for such patients. Collaboration between the patient, neurologist, and obstetrician is important for managing this dynamic and complex clinical situation.


Asunto(s)
Epilepsia/terapia , Obstetricia , Complicaciones del Embarazo/terapia , Embarazo , Femenino , Humanos , Complicaciones del Embarazo/etiología
5.
Am J Perinatol ; 25(9): 587-9, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18850518

RESUMEN

Patients with multiple gestations, low-lying placentas, velamentous cord insertions, and history of assisted conception should be evaluated carefully for a vasa previa. Serial surveillance for signs of preterm labor and elective cesarean delivery at 34 to 35 weeks after corticosteroids for fetal lung maturity is a reasonable management strategy for vasa previa in multiple gestations.


Asunto(s)
Fertilización In Vitro/efectos adversos , Complicaciones del Trabajo de Parto/diagnóstico por imagen , Enfermedades Placentarias/diagnóstico por imagen , Placenta/irrigación sanguínea , Resultado del Embarazo , Embarazo Múltiple , Cesárea , Femenino , Monitoreo Fetal/métodos , Estudios de Seguimiento , Humanos , Edad Materna , Monitoreo Fisiológico/métodos , Placenta/anomalías , Enfermedades Placentarias/fisiopatología , Embarazo , Técnicas Reproductivas Asistidas , Medición de Riesgo , Muestreo , Gemelos , Ultrasonografía Prenatal , Adulto Joven
6.
Am J Obstet Gynecol ; 199(3): 283.e1-3, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18771984

RESUMEN

OBJECTIVE: The purpose of this study was to evaluate the Down syndrome detection rate at a 5% screen positive rate in first-trimester screening for twins. STUDY DESIGN: This was a retrospective study from August 2005 to July 2007 of twins who underwent first-trimester screening with nuchal translucency, nasal bone, pregnancy-associated plasma protein-A, and free beta-hCG. Risks were calculated on the basis of the Fetal Medicine Foundation twin algorithm. The model simulated distributions of unaffected and affected cases at 12 weeks of gestation. RESULTS: Two thousand ninety-four twin pregnancies (4188 fetuses) met the inclusion criteria. The addition of nasal bone to nuchal translucency, pregnancy-associated plasma protein-A, and free beta-hCG increased the Down syndrome detection rate from 79-89% at a 5% screen-positive rate. CONCLUSION: In twins, first-trimester screening with nasal bone is valuable. The improved Down syndrome detection rate can help these high-risk patients with the decision-making process of whether to pursue invasive testing with its associated pregnancy loss risk.


Asunto(s)
Síndrome de Down/diagnóstico , Gemelos , Adulto , Gonadotropina Coriónica Humana de Subunidad beta/sangre , Síndrome de Down/diagnóstico por imagen , Femenino , Humanos , Edad Materna , Medida de Translucencia Nucal , Embarazo , Primer Trimestre del Embarazo , Proteína Plasmática A Asociada al Embarazo/análisis , Estudios Retrospectivos
7.
Am J Obstet Gynecol ; 199(1): 62.e1-6, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18585522

RESUMEN

OBJECTIVE: The purpose of this study was to calculate first and second trimester reference ranges and within-woman correlations for TSH, free T4, and thyroid antibodies. STUDY DESIGN: TSH, free T4, and thyroid antibodies were measured in paired sera from 9562 women in the FaSTER trial of Down syndrome screening. RESULTS: The median first trimester TSH (1.05 mIU/L) is lower than the second (1.23 mIU/L); and 98th centile is higher (4.15 vs 3.77 mIU/L). Within-woman paired TSH correlations are moderately strong (r(2) = 0.64). Among women with first trimester TSH values above the 98th centile, second trimester values are over the 95th centile in 68%. Median first trimester free T4 values (1.10 ng/dL) are higher than second (1.01 ng/dL). Paired free T4 measurements correlate weakly (r(2) = 0.23). Among women with first trimester free T4 values below the 2nd centile, second trimester values are below the 5th centile in 32%. Antibody measurements correlate strongly between trimesters (thyroperoxidase r(2) = 0.79, thyroglobulin r(2) = 0.83). CONCLUSION: TSH and free T4 measurements require gestation-specific reference ranges.


Asunto(s)
Autoanticuerpos/sangre , Tirotropina/sangre , Tiroxina/sangre , Adulto , Femenino , Edad Gestacional , Humanos , Embarazo , Primer Trimestre del Embarazo/sangre , Segundo Trimestre del Embarazo/sangre , Valores de Referencia
8.
Obstet Gynecol ; 112(1): 85-92, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18591312

RESUMEN

OBJECTIVE: To estimate whether maternal thyroid hypofunction is associated with complications. METHODS: A total of 10,990 patients had first- and second-trimester serum assayed for thyroid-stimulating hormone (TSH), free thyroxine (freeT4), and antithyroglobulin and antithyroid peroxidase antibodies. Thyroid hypofunction was defined as 1) subclinical hypothyroidism: TSH levels above the 97.5th percentile and free T4 between the 2.5th and 97.5th percentiles or 2) hypothyroxinemia: TSH between the 2.5th and 97.5th percentiles and free T4 below the 2.5th percentile. Adverse outcomes were evaluated. Patients with thyroid hypofunction were compared with euthyroid patients (TSH and free T4 between the 2.5th and 97.5th percentiles). Patients with and without antibodies were compared. Multivariable logistic regression analysis adjusted for confounders was used. RESULTS: Subclinical hypothyroidism was documented in 2.2% (240 of 10,990) in the first and 2.2% (243 of 10,990) in the second trimester. Hypothyroxinemia was documented in 2.1% (232 of 10,990) in the first and 2.3% (247 of 10,990) in the second trimester. Subclinical hypothyroidism was not associated with adverse outcomes. In the first trimester, hypothyroxinemia was associated with preterm labor (adjusted odds ratio [aOR] 1.62; 95% confidence interval [CI] 1.00-2.62) and macrosomia (aOR 1.97; 95% CI 1.37-2.83). In the second trimester, it was associated with gestational diabetes (aOR 1.7; 95% CI 1.02-2.84). Fifteen percent (1,585 of 10,990) in the first and 14% (1,491 of 10,990) in the second trimester had antithyroid antibodies. When both antibodies were positive in either trimester, there was an increased risk for preterm premature rupture of membranes (P=.002 and P<.001, respectively). CONCLUSION: Maternal thyroid hypofunction is not associated with a consistent pattern of adverse outcomes. LEVEL OF EVIDENCE: II.


Asunto(s)
Hipotiroidismo/complicaciones , Complicaciones del Embarazo , Resultado del Embarazo , Adulto , Autoanticuerpos/efectos adversos , Femenino , Rotura Prematura de Membranas Fetales/etiología , Humanos , Hipotiroidismo/inmunología , Oportunidad Relativa , Embarazo , Complicaciones del Embarazo/inmunología , Primer Trimestre del Embarazo , Segundo Trimestre del Embarazo , Riesgo , Tiroglobulina/efectos adversos , Pruebas de Función de la Tiroides
9.
J Clin Endocrinol Metab ; 93(9): 3341-7, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18544616

RESUMEN

OBJECTIVE: The objective of the study was to further explore relationships between human chorionic gonadotropin (hCG), TSH, and free T4 in pregnant women at 11 through 18 wk gestation. STUDY DESIGN: The design of the study was to analyze hCG in comparison with TSH and free T4, in paired first- and second-trimester sera from 9562 women in the First and Second Trimester Evaluation of Risk for Fetal Aneuploidy trial study. RESULTS: hCG is strongly correlated with body mass index, smoking, and gravidity. Correlations with selected maternal covariates also exist for TSH and free T4. As hCG deciles increase, body mass index and percent of women who smoke both decrease, whereas the percent of primigravid women increases (P < 0.0001). hCG/TSH correlations are weak in both trimesters (r2 = 0.03 and r2 = 0.02). TSH concentrations at the 25th and fifth centiles become sharply lower at higher hCG levels, whereas 50th centile and above TSH concentrations are only slightly lower. hCG/free T4 correlations are weak in both trimesters (r2 = 0.06 and r2 = 0.003). At 11-13 wk gestation, free T4 concentrations rise uniformly at all centiles, as hCG increases (test for trend, P < 0.0001), but not at 15-18 wk gestation. Multivariate analyses with TSH and free T4 as dependent variables and selected maternal covariates and hCG as independent variables do not alter these observations. CONCLUSIONS: In early pregnancy, a woman's centile TSH level appears to determine susceptibility to the TSH being suppressed at any given hCG level, suggesting that hCG itself may be the primary analyte responsible for stimulating the thyroid gland. hCG affects lower centile TSH values disproportionately.


Asunto(s)
Gonadotropina Coriónica/fisiología , Primer Trimestre del Embarazo/sangre , Segundo Trimestre del Embarazo/sangre , Tirotropina/antagonistas & inhibidores , Adulto , Gonadotropina Coriónica/sangre , Gonadotropina Coriónica/metabolismo , Estudios de Cohortes , Femenino , Humanos , Embarazo , Primer Trimestre del Embarazo/metabolismo , Segundo Trimestre del Embarazo/metabolismo , Tirotropina/sangre , Tirotropina/metabolismo , Tiroxina/sangre
10.
Semin Perinatol ; 32(3): 206-12, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18482623

RESUMEN

Growth abnormalities which include intrauterine growth restriction and weight discordance between twins are common in pregnancies complicated by multiple gestations and may be associated with poor perinatal outcomes. Knowledge of chorionicity is paramount when managing a multiple pregnancy. Monochorionic twins are at greater risk than dichorionic twins for growth issues, which may result in long-term complications including adverse neurological sequelae for the offspring. The purpose of the following article is to define normal and abnormal growth in multiples. In addition, the management of growth abnormalities in relationship to chorionicity will be discussed.


Asunto(s)
Corion/fisiología , Retardo del Crecimiento Fetal/diagnóstico , Tamaño de los Órganos/fisiología , Placenta/fisiología , Embarazo Múltiple , Corion/diagnóstico por imagen , Femenino , Retardo del Crecimiento Fetal/etiología , Peso Fetal , Edad Gestacional , Humanos , Placenta/patología , Embarazo , Resultado del Embarazo , Factores de Riesgo , Gemelos Dicigóticos , Gemelos Monocigóticos , Ultrasonografía
11.
Am J Obstet Gynecol ; 199(2): 129.e1-6, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18448078

RESUMEN

OBJECTIVE: The purpose of this study was to examine how closely hypothyroidism management in the general pregnancy population satisfies recently issued guidelines and to determine whether improvements are indicated. STUDY DESIGN: This was an observational study in which women at 5 recruitment centers in the first- and second-trimester evaluation of risk for aneuploidy trial allowed the use of sequentially obtained first- and second-trimester sera for additional research. Three hundred eighty-nine women had hypothyroidism by self-report. Thyroid-related measurements were performed on all samples between July 2004 and May 2005. RESULTS: Forty-three percent of the thyroid-stimulating hormone (TSH) values are at or above recently recommended guidelines in the first trimester (2.5 mU/L), as opposed to 33% of the values in the second trimester (3.0 mU/L). Twenty percent of the TSH values are at or above a less restrictive 98th percentile of normal in the first trimester, as opposed to 23% of the values in the second trimester. Mean TSH levels are higher in women with antibodies. Free thyroxine values are unremarkable. CONCLUSION: Future strategies should focus on more effectively treating women with hypothyroidism who have persistently elevated TSH values.


Asunto(s)
Hipotiroidismo/sangre , Complicaciones del Embarazo/sangre , Primer Trimestre del Embarazo/sangre , Segundo Trimestre del Embarazo/sangre , Tirotropina/sangre , Tiroxina/sangre , Adulto , Autoanticuerpos/sangre , Femenino , Guías como Asunto , Humanos , Guías de Práctica Clínica como Asunto , Embarazo
12.
Am J Perinatol ; 25(5): 271-5, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18401840

RESUMEN

Our objective was to compare the incidence of recurrent spontaneous preterm delivery (SPTD) in patients with cervical cerclage treated with weekly 17 alpha-hydroxyprogesterone caproate (17P) injections versus daily outpatient nursing surveillance (ONS) without 17P. Included in this retrospective cohort study were singleton gestations with cerclage placed at the discretion of the provider due to prior SPTD, delivering between January 1, 2004 and May 1, 2006. The study group (n = 232) consisted of women receiving once-weekly nursing visit and 17P injection. The control group (n = 1650) consisted of women enrolled for ONS (twice-daily electronic uterine contraction monitoring and nursing assessment). Data were further stratified by the number of prior preterm deliveries (1, > 1). Primary study outcome was the incidence of SPTD. No difference in rates of recurrent SPTD at < 37 or < 35 weeks were observed between the study and control groups. Study patients were less likely to be diagnosed with preterm labor (PTL) than controls (45.7% versus 70.8%, respectively; P < 0.001). The incidence of preterm premature rupture of membranes was similar between the groups (8.6% versus 8.1%; P = 0.770). We concluded that the incidence of recurrent SPTD was similar in women with cerclage treated with 17P or ONS, although women receiving 17P had a lower incidence of PTL. This benefit of 17P should be considered when managing patients with prior SPTD and cerclage.


Asunto(s)
Cerclaje Cervical , Antagonistas de Estrógenos/uso terapéutico , Hidroxiprogesteronas/uso terapéutico , Trabajo de Parto Prematuro/prevención & control , Caproato de 17 alfa-Hidroxiprogesterona , Adulto , Estudios de Cohortes , Femenino , Edad Gestacional , Humanos , Atención de Enfermería , Embarazo , Resultado del Embarazo , Estudios Retrospectivos
13.
Obstet Gynecol ; 110(3): 669-74, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17766616

RESUMEN

OBJECTIVE: To examine how practicing obstetricians evaluate and manage thrombophilias in selected clinical situations. METHODS: A questionnaire investigating knowledge and practice patterns pertaining to thrombophilia was mailed to 300 randomly selected American College of Obstetricians and Gynecologists Fellows and Junior Fellows in February 2005. RESULTS: Approximately 50% (151) of questionnaires were returned. Statistical analysis focused on the 104 responding obstetricians. The majority (greater than 70%) know which thrombophilias are inherited and which are acquired. More than 50% send an inherited thrombophilia panel and antiphospholipid antibodies on patients with a history of fetal demise, intrauterine growth restriction (less than 5th percentile), abruption, and severe preeclampsia. Ninety-two percent test patients with recurrent miscarriages for antiphospholipid antibodies. Despite no clear evidence, 80% also test these patients for inherited thrombophilias. The majority intervene with either thromboprophylaxis or low-dose aspirin when managing patients at risk for thromboembolism. Seventy percent use low-molecular-weight (fractionated) heparin for patients requiring therapeutic anticoagulation, while 62% also use it for prophylactic anticoagulation. Thirty-eight percent of physicians using low-molecular-weight (fractionated) heparin monitor anti-factor Xa levels. The majority (56%) felt their residency training with regard to thrombophilia was barely adequate. Only 8% felt their training was comprehensive, while 36% felt it was adequate. CONCLUSION: Most responding obstetricians do not manage thrombophilia patients according to expert opinion. Despite the fact that often there is no clear evidence for treatment, many physicians are inclined to intervene in patients at risk for thromboembolism. Educational endeavors are needed to guide obstetricians caring for patients at risk for thromboembolism. LEVEL OF EVIDENCE: III.


Asunto(s)
Anticoagulantes/uso terapéutico , Ginecología/normas , Obstetricia/normas , Pautas de la Práctica en Medicina , Complicaciones Hematológicas del Embarazo/tratamiento farmacológico , Trombofilia/tratamiento farmacológico , Adulto , Actitud del Personal de Salud , Femenino , Encuestas de Atención de la Salud , Conocimientos, Actitudes y Práctica en Salud , Heparina de Bajo-Peso-Molecular/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Embarazo , Complicaciones Hematológicas del Embarazo/diagnóstico , Complicaciones Hematológicas del Embarazo/genética , Complicaciones Hematológicas del Embarazo/prevención & control , Calidad de la Atención de Salud , Encuestas y Cuestionarios , Trombofilia/diagnóstico , Trombofilia/genética , Trombofilia/prevención & control , Estados Unidos
14.
Diabetes Care ; 30(9): 2277-80, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17563346

RESUMEN

OBJECTIVE: Progesterone has a known diabetogenic effect. We sought to determine whether the incidence of gestational diabetes mellitus (GDM) is altered in women receiving weekly 17alpha-hydroxyprogesterone caproate (17P) prophylaxis for the prevention of recurrent preterm birth. RESEARCH DESIGN AND METHODS: Singleton gestations in women having a history of preterm delivery were identified from a database containing prospectively collected information from women receiving outpatient nursing services related to a high-risk pregnancy. Included were patients enrolled for outpatient management at <27 weeks' gestation with documented pregnancy outcome and delivery at >28 weeks. Patients with preexisting diabetes were excluded. The incidence of GDM was compared between patients who received prophylactic intramuscular 17P (250-mg weekly injection initiated between 16.0 and 20.9 weeks' gestation) and those who did not. RESULTS: Maternal BMI and age were similar. The incidence of GDM was 12.9% in the 17P group (n = 557) compared with 4.9% in control subjects (n = 1,524, P < 0.001; odds ratio 2.9 [95% CI 2.1-4.1]). CONCLUSIONS: The use of 17P for the prevention of recurrent preterm delivery is associated with an increased risk of developing GDM. Early GDM screening is appropriate for women receiving 17P prophylaxis.


Asunto(s)
17-alfa-Hidroxiprogesterona/efectos adversos , Diabetes Gestacional/inducido químicamente , Nacimiento Prematuro/prevención & control , Tocolíticos/efectos adversos , 17-alfa-Hidroxiprogesterona/administración & dosificación , 17-alfa-Hidroxiprogesterona/uso terapéutico , Adolescente , Adulto , Caproatos , Diabetes Gestacional/epidemiología , Femenino , Humanos , Incidencia , Inyecciones Intramusculares , Embarazo , Recurrencia , Tocolíticos/administración & dosificación , Tocolíticos/uso terapéutico
16.
Clin Perinatol ; 33(4): 777-92; abstract viii, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17148004

RESUMEN

Multiple pregnancies currently account for 3% of all births in the United States but are disproportionately responsible for larger rates of prematurity and significant neonatal morbidity. The mean birth age for most multi-fetal pregnancies occurs during the late preterm period when both spontaneous preterm labor and iatrogenic premature birth because of obstetrical or maternal complications are common. Multiples pose numerous unique challenges, emphasizing the significant impact of plurality on late preterm births.


Asunto(s)
Enfermedades del Prematuro/epidemiología , Embarazo Múltiple , Nacimiento Prematuro/epidemiología , Nacimiento Prematuro/prevención & control , Femenino , Transfusión Feto-Fetal/epidemiología , Humanos , Mortalidad Infantil , Recién Nacido de Bajo Peso , Recién Nacido , Recien Nacido Prematuro , Enfermedades del Sistema Nervioso/epidemiología , Embarazo , Complicaciones del Embarazo/epidemiología , Nacimiento Prematuro/etiología
17.
Am J Obstet Gynecol ; 195(3): 863-7, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16949427

RESUMEN

OBJECTIVE: We sought to determine the accuracy of antenatal diagnosis of twin chorionicity at a single tertiary care center and assess the consequences of incorrect diagnoses. STUDY DESIGN: Twins with chorionicity diagnosed by ultrasound < or = 24 weeks' gestation were retrospectively reviewed. Chorionicity was assigned by sonographic findings including placental location(s), the lambda and T-signs, and/or fetal gender(s). Postnatal diagnosis was determined by placental histopathologic examination. Medical records of antenatal-postnatal discordant chorionicities were reviewed for adverse sequelae. RESULTS: Chorionicity was correctly assigned antenatally in 392/410 (95.6%) twins. The sensitivity, specificity, and positive and negative predictive values of monochorionicity assessed < or = 14 weeks were 89.8%, 99.5%, 97.8%, and 97.5%. Corresponding statistical values for the second trimester were 88.0%, 94.7%, 88.0%, and 94.7%. Two cases of inaccurate antenatal diagnoses affected patient counseling or were associated with adverse clinical outcomes. CONCLUSION: Antenatal assessment of chorionicity is accurate; however, incorrect diagnoses do occur and can affect reliable patient counseling and management.


Asunto(s)
Corion/anomalías , Corion/diagnóstico por imagen , Embarazo Múltiple , Ultrasonografía Prenatal , Femenino , Edad Gestacional , Humanos , Placenta/anomalías , Placenta/patología , Embarazo , Primer Trimestre del Embarazo , Segundo Trimestre del Embarazo , Estudios Retrospectivos , Sensibilidad y Especificidad , Gemelos
18.
Semin Perinatol ; 30(2): 103-12, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16731285

RESUMEN

Multiple gestations present unique challenges to the modern obstetrician. Many twin and high-order multiple pregnancies are delivered between 34 and 37 weeks' gestation either secondary to preterm labor or obstetrical complications necessitating intervention. Recognizing the increasing prevalence of multiple gestations and the impact of late preterm deliveries in modern practice, this review analyzes the impact of multiple pregnancies on perinatal outcomes, reviews the strategies to prevent preterm labor, and summarizes potential indications for late preterm delivery. In this paper, "late preterm" has been used instead of "near-term," as the former was considered more appropriate to reflect this subgroup of preterm infants in a workshop on this topic held in July 2005, organized by the National Institute of Child Health and Human Development.


Asunto(s)
Edad Gestacional , Trabajo de Parto Prematuro , Embarazo Múltiple , Femenino , Retardo del Crecimiento Fetal/etiología , Humanos , Mortalidad Infantil , Recién Nacido de Bajo Peso , Recién Nacido , Embarazo , Resultado del Embarazo , Técnicas Reproductivas Asistidas/efectos adversos
19.
Am J Perinatol ; 23(1): 15-20, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16450267

RESUMEN

The purpose of this study was to determine the management of postterm pregnancy by contemporary practicing obstetricians. A questionnaire investigating practice patterns pertaining to postterm pregnancy was mailed to 1000 randomly selected American College of Obstetricians and Gynecologists (ACOG) Fellows and Junior Fellows in March 2004. The response rate was 52.2% (522/1000). Statistical analysis included the answers from the 420 practicing obstetricians. Males comprised 55.7% (234/420) of the responding obstetricians. The majority of responding obstetricians (95.4%) rated their residency training regarding management of postterm pregnancy as adequate or comprehensive. Forty-eight percent define postterm pregnancy as 42 weeks gestation or greater, whereas 43.1% consider 41 weeks gestation or greater to be postterm. Seventy-three percent routinely induce low-risk patients with singletons at 41 weeks gestation. If patients decline induction at 41 weeks or if the practitioner does not induce patients until after 41 weeks gestation, the majority of respondents (64.8% and 65.0%, respectively) start postterm pregnancy fetal testing in singletons at 41 weeks and obtain testing twice weekly. Most (64.6%) use cervical ripening agents when inducing both nulliparous and multiparous patients with unfavorable cervices. The majority of practitioners (97.3%) do not use prostaglandins when inducing postterm patients with one previous cesarean delivery. Although most respondents manage postterm pregnancy according to recent ACOG educational materials with regard to antenatal fetal surveillance and methods of induction, the majority induce patients with singleton postterm pregnancies at 41 weeks gestation rather than at 42 weeks gestation.


Asunto(s)
Obstetricia/estadística & datos numéricos , Pautas de la Práctica en Medicina , Embarazo Prolongado , Femenino , Monitoreo Fetal , Edad Gestacional , Humanos , Trabajo de Parto Inducido , Embarazo , Encuestas y Cuestionarios , Gemelos
20.
Obstet Gynecol ; 107(1): 11-7, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16394034

RESUMEN

OBJECTIVE: To assess obstetricians' practice patterns and knowledge regarding screening for Down syndrome. METHODS: A questionnaire was mailed to 1,105 American College of Obstetricians and Gynecologists Fellows and Junior Fellows in 2004. RESULTS: Sixty percent of questionnaires were returned. Statistical analyses were limited to the 532 practicing obstetricians. Greater than 80% felt their training and experience qualified them to counsel patients about genetic issues in pregnancy. However, 45% rated their residency training regarding prenatal diagnosis as barely adequate or nonexistent. American College of Obstetricians and Gynecologists publications were rated by 86% as an important source of information on genetic counseling. Seventy-eight percent of practitioners counsel all obstetric patients about risks for fetal aneuploidy, and 67% provide counseling for heritable genetic abnormalities. Although the majority (99%) offer second-trimester Down syndrome screening, only 55% also offer first-trimester screening for Down syndrome. Almost one half (49%) use the quad screen, and 6% offer integrated first- and second-trimester screening. The majority (88%) routinely offer amniocentesis to patients who are at elevated risk for genetic abnormalities, whereas 44% also offer chorionic villus sampling. Few (2%) perform chorionic villus sampling. CONCLUSION: Most obstetricians manage patients at risk for fetal genetic abnormalities according to American College of Obstetricians and Gynecologists educational materials. This survey identified deficiencies related to Down syndrome screening, including a limited number of practitioners performing chorionic villus sampling and physicians' own perception that training regarding genetic counseling should be improved. Educational strategies are needed to address these deficiencies before first-trimester screening programs are widely implemented. LEVEL OF EVIDENCE: III.


Asunto(s)
Síndrome de Down/diagnóstico , Síndrome de Down/genética , Pruebas Genéticas/normas , Conocimientos, Actitudes y Práctica en Salud , Pautas de la Práctica en Medicina , Amniocentesis , Actitud del Personal de Salud , Femenino , Pruebas Genéticas/tendencias , Edad Gestacional , Ginecología/normas , Ginecología/tendencias , Encuestas de Atención de la Salud , Humanos , Masculino , Obstetricia/normas , Obstetricia/tendencias , Embarazo , Probabilidad , Calidad de la Atención de Salud , Estadísticas no Paramétricas , Encuestas y Cuestionarios , Ultrasonografía Prenatal
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...